Clinical trial
A Study to Test the Effectiveness of Virulizin® Given in Combination With…
NCT00040092 · Aptose Biosciences Inc., Industry · Completed
Key facts
| NCT number | NCT00040092 |
|---|---|
| Title | A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer |
| Lead sponsor | Aptose Biosciences Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | Virulizin® |
| Enrollment | 400 |
| Start date | Jul 1, 2002 |
| Primary completion | Jul 1, 2005 |
| First posted | Jun 20, 2002 |
| Last update posted | Jan 7, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: